Tirzepatide Clinics in Delaware
5 physician-supervised clinics prescribing Tirzepatide for Delaware residents — 3 in-state locations plus 2 telehealth providers. Compare consultation fees, treatment areas, and access before you enquire.
In-state clinics (3)
Physician-supervised · Board certified
Physician-supervised · Board certified
Physician-supervised · Board certified
Telehealth providers serving Delaware (2)
Physician-supervised · Board certified
Physician-supervised · Board certified
Tirzepatide clinics in other states
Tirzepatide in Delaware
Peptide Finder currently lists 5 physician-supervised clinics prescribing Tirzepatide for Delaware residents - 3 with an in-state locations and 2 licensed telehealth providers serving the state. Telehealth availability in Delawaredepends on each clinic's licensure and operations, so confirm coverage when you enquire.
Tirzepatide is an FDA-approved dual GIP and GLP-1 receptor agonist - the first of its kind. Sold as Mounjaro for type 2 diabetes and Zepbound for weight management, it outperforms semaglutide in head-to-head weight loss trials.
Informational only - not medical advice. Whether Tirzepatide is appropriate, legal, or available to you in Delaware is decided by a licensed US prescriber after an individual assessment.
Read the full Tirzepatide guide →